Free Trial

Short Interest in Givaudan SA (OTCMKTS:GVDNY) Grows By 135.1%

Givaudan logo with Basic Materials background

Givaudan SA (OTCMKTS:GVDNY - Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 8,700 shares, an increase of 135.1% from the December 15th total of 3,700 shares. Based on an average daily volume of 81,500 shares, the short-interest ratio is presently 0.1 days.

Givaudan Stock Performance

OTCMKTS GVDNY traded down $0.58 during trading on Tuesday, hitting $84.26. The stock had a trading volume of 49,571 shares, compared to its average volume of 42,608. Givaudan has a 12 month low of $75.55 and a 12 month high of $110.32. The company's 50-day moving average price is $88.00 and its two-hundred day moving average price is $95.77. The company has a current ratio of 1.43, a quick ratio of 0.94 and a debt-to-equity ratio of 0.99.

Analyst Ratings Changes

GVDNY has been the subject of a number of research analyst reports. Barclays cut Givaudan from a "hold" rating to a "strong sell" rating in a report on Friday, November 15th. Citigroup lowered shares of Givaudan from a "buy" rating to a "neutral" rating in a research report on Thursday, October 17th.

View Our Latest Stock Report on Givaudan

Givaudan Company Profile

(Get Free Report)

Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Givaudan Right Now?

Before you consider Givaudan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.

While Givaudan currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines